Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Recruiting

Precise Robotically IMplanted Brain-Computer InterfacE

NCT06429735

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Cervical Spinal Cord Injury, +20 more
Locations: Barrow Neurological Institute Phoenix, Arizona, United States

University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration

NCT07316413

Conditions: Brain Diseases, Central Nervous System Diseases, Cortical Basal Syndrome (CBS), +17 more
Locations: IRCCS Istituto Centro San Giovanni Di Dio - Fatebenefratelli Brescia Brescia, Italy

View Trial Details

Recruiting

LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS

NCT07312240

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Istituto Auxologico Italiano IRCCS Milan, Lombardy, Italy

View Trial Details

Recruiting

Video-Based Proprioceptive Exercise Program in ALS

NCT07292545

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Tarsus University Mersin, TARSUS, Turkey (Türkiye)

View Trial Details

Recruiting

Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders

NCT05116943

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

NCT07268833

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +14 more
Locations: Azienda Ospedaliero Universitaria di Cagliari Monserrato, California, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta Milan, Italy

IRCCS Ospedale San Raffaele SRL Milan, Italy

Azienda Ospedaliera Universitaria Federico II Naples, Italy

View Trial Details

Recruiting

Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.

NCT04882904

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: CHR Citadelle Liège, Belgium

View Trial Details

Recruiting

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder

NCT06363357

Conditions: ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +29 more
Locations: Seoul National University Hospital Seoul, Jongno-gu, South Korea

View Trial Details

Recruiting

Imaging Biomarkers in ALS

NCT02567136

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +9 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

NCT06094205

Conditions: Amyotrophic Lateral Sclerosis, Anarthria, Articulation Disorders, +44 more
Locations: University of California, Davis Sacramento, California, United States

View Trial Details

TDP-43 Proteinopathies

TDP-43 Proteinopathies trial results

Related conditions